General Surgery Devices are used in diagnostic and surgical interventions primarily for the gastrointestinal tract, abdomen, and pelvis. Electrosurgery makes use of high-frequency electrical current to coagulate, cut, desiccate, fulgurate, ablate and shrink tissue and can be performed using various forms of energy such as radiofrequency, microwave, cryoablation, irreversible electroporation, in conjunction with a specialized instrument. GlobalData uses proprietary data and analytics to provide a comprehensive report on the surgical energy instruments devices market, including market shares of different players within Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the surgical energy instruments market in Australia was Ethicon Endo-Surgery followed by Medtronic, Applied Medical, Olympus, Stryker, B. Braun Melsungen, ConMed, Boston Scientific, ERBE Elektromedizin, Integra LifeSciences, AngioDynamics, Utah Medical Products, KLS Martin and Symmetry Surgical.
Surgical Energy Instruments are frequently used during surgical operations helping to prevent blood loss in hospital for inpatient and outpatient interventions. Surgical Energy Instruments Include Basic Energy Instruments, Advanced Energy Instruments and Alternative Energy Instruments. Basic Energy Instruments include Monopolar Instruments and Bipolar Instruments. Advanced Energy Instruments include Advanced Bipolar Instruments and Ultrasonic Instruments. Alternative Energy Instruments include Argon Plasma Instruments, Microwave Antennas, Cryoablation Probes, and Irreversible Electroporation Probes.
The value of the surgical energy instruments devices market within Australia was expected to be over $100m in 2023.
For the latest complete market share analysis of surgical energy instruments device market in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
